Johnson & Johnson Q4 Earnings Highlight Bullish Path In 2023


  • J&J reported its Q4 results with EPS beating expectations.
  • The company is proving capable of maintaining organic sales growth while supporting margins through cost savings initiatives.
  • We like the stock following the recent selloff and highlight the compelling value for a high-quality market leader.
Irvine Exteriors And Landmarks - 2020

AaronP/Bauer-Griffin/GC Images via Getty Images

Johnson & Johnson (NYSE:JNJ) just released its fourth quarter and full-year financial results, capping off a resilient 2022 despite macro headwinds. The takeaway from the report is that the company was able to drive earnings higher largely through price hikes, balancing out

Disclosure: I/we have a beneficial long position in the shares of SPY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Add some conviction to your trading! Take a look at our exclusive stock picks. Join a winning team that gets it right. Click here for a two-week free trial.

Leave a Reply

Your email address will not be published. Required fields are marked *